News items related to:


Warning: Undefined property: WP_Post_Type::$slug in /home/trisatrisa/public_html/wp-content/themes/mmaffordable/archive.php on line 25

  • 28 May 2020

    Global Citizen and the European Commission announce the Global Goal: Unite for Our Future Campaign to ensure that everyone has...

  • 27 May 2020

    A multi-country, 397-person uncontrolled phase III trial of remdesivir in people with severe COVID-19 (which excluded critically ill people on...

  • 25 May 2020

    WHO suspends use of hydroxychloroquine in the Solidarity trial, based on data published in Lancet.

  • 24 May 2020

    Bangladesh’s Eskayef pharmaceuticals received marketing approval for Remivir, its generic version of remdesivir; because it is a least-developed nation it...

  • 22 May 2020

    • Lancet publishes a multinational registry analysis reporting increased rates of cardiac arrhythmia and poorer survival among people with COVID-19...

  • 21 May 2020

    OWS announces a $1.2 billion investment in the Oxford University vaccine candidate AZD 1222, which is being developed in partnership...

  • 19 May 2020

    • Experts critique press release of results from Moderna’s phase I vaccine trial, saying that more data are needed, triggering...

  • 18 May 2020

    • Moderna issues a press release with “positive interim data” from its phase I trial of mRNA-1273 and plans to...

  • 16 May 2020

    Lancet publishes results from a randomized, placebo-controlled, double- blinded trial of remdesivir (in combination with other medicines, including LPV/r, interferons,...

  • 15 May 2020

    Launch of Operation Warp Speed (OWS), a US $10 billion public-private partnership, to develop, manufacture and distribute COVID-19 vaccines, therapeutics,...

  • 14 May 2020

    • STAT publishes an opinion piece suggesting that Gilead prioritize development of a pro-drug, GS-441524, based on favorable pre-clinical data....

  • 12 May 2020

    Gilead signs voluntary licenses (VL) with five generics producers in India and Pakistan (Cipla, Hetero Labs, Jubilant Lifesciences, Mylan, and...